Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Andrea, Alonci"'
Autor:
Alessandro Allegra, Vincenzo Rizzo, Vanessa Innao, Angela Alibrandi, Anna Mazzeo, Rossana Leanza, Carmen Terranova, Luca Gentile, Paolo Girlanda, Andrea Gaetano Allegra, Andrea Alonci, Caterina Musolino
Publikováno v:
Archives of Medical Science, Vol 18, Iss 3, Pp 696-703 (2021)
Introduction In the past few years, treatment of multiple myeloma has undergone a deep change for the employment of novel treatment comprising proteasome inhibitors. Bortezomib is a first-line drug in therapy of multiple myeloma. The onset of periphe
Externí odkaz:
https://doaj.org/article/4ae474683a144f25b8f74c7cf877c99c
Autor:
Sabina Russo, Giuseppa Penna, Arianna D’Angelo, Alessandro Allegra, Andrea Alonci, Caterina Musolino
Publikováno v:
Clinical Management Issues, Vol 5, Iss 5S, Pp 7-14 (2015)
This article describes the case of a 44 year old man, at high-risk according to the Sokal Index, after CML Ph+ diagnosis, started imatinib at the standard dose (400 mg/day). Initially he reached optimal response, but at month 12, because of a loss of
Externí odkaz:
https://doaj.org/article/3f668b47cbcb49a38a9f7ff72e1b146e
Autor:
Caterina Musolino, Alessandro Allegra, Carmen Mannucci, Sabina Russo, Andrea Alonci, Valerio Maisano, Gioacchino Calapai, Sebastiano Gangemi
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 2, Pp 168-171 (2015)
Imatinib mesylate is a small-molecule tyrosine kinase inhibitor (TKi) designed to target c-ABL and BCR-ABL, approved for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors. Adverse cutaneous reactions induced by imatinib ar
Externí odkaz:
https://doaj.org/article/afc49c04de1642e59edf53877ae7701b
Autor:
Andrea Gaetano Allegra, Rossana Leanza, Vincenzo Rizzo, Anna Mazzeo, Vanessa Innao, Caterina Musolino, Carmen Terranova, Paolo Girlanda, Luca Gentile, Andrea Alonci, Alessandro Allegra, Angela Alibrandi
Publikováno v:
Archives of Medical Science.
IntroductionIn the past few years, treatment of multiple myeloma has undergone a deep change for the employment of novel treatment comprising proteasome inhibitors. Bortezomib is a first-line drug in therapy of multiple myeloma. The onset of peripher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c504553e04d579e53f1b0e6a484cec
https://doi.org/10.5114/aoms/114269
https://doi.org/10.5114/aoms/114269
Autor:
Demetrio Gerace, Alessandro Allegra, Vanessa Innao, Caterina Musolino, Sabina Russo, Andrea Alonci
Publikováno v:
Cancer Investigation. 35:1-22
Curcumin has been shown to have a wide variety of therapeutic effects, ranging from anti-inflammatory, chemopreventive, anti-proliferative, and anti-metastatic. This review provides an overview of the recent research conducted to overcome the problem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4af9a719fcdea2000dd059be1ad3f3d0
https://doi.org/10.1080/07357907.2016.1247166
https://doi.org/10.1080/07357907.2016.1247166
Autor:
Sabina Russo, Valerio Maisano, Sebastiano Gangemi, Carmen Mannucci, Andrea Alonci, Gioacchino Calapai, Caterina Musolino, Alessandro Allegra
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 2, Pp 168-171 (2015)
Turkish Journal of Hematology
Turkish Journal of Hematology
Imatinib mesylate is a small-molecule tyrosine kinase inhibitor (TKi) designed to target c-ABL and BCR-ABL, approved for the treatment of chronic myeloid leukemia and gastrointestinal stromal tumors. Adverse cutaneous reactions induced by imatinib ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d458e9556f8297b91028c439f617771
http://www.tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-76402&look4=
http://www.tjh.com.tr/jvi.aspx?pdir=tjh&plng=eng&un=TJH-76402&look4=
Autor:
Demetrio Gerace, Caterina Musolino, Andrea Alonci, Alessandro Allegra, Sabina Russo, Vanessa Innao, Doriana Vaddinelli, Andrea Gaetano Allegra
Publikováno v:
European journal of cancer care. 26(6)
The assessment of the effectiveness of chemotherapy in oncology cannot disregard the concept of minimal residual disease (MRD). In fact, the efforts of numerous scientific groups all over the world are currently focusing on this issue, with the sole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b359cb45256cea55b3b2e32de243a8d0
https://pubmed.ncbi.nlm.nih.gov/28671297
https://pubmed.ncbi.nlm.nih.gov/28671297
Autor:
Sabina Russo, Arianna D'Angelo, Bruna Greve, Sara Catena, Alessandro Allegra, Caterina Musolino, Giuseppa Penna, Andrea Alonci, Demetrio Gerace
Publikováno v:
Hematological Oncology. 30:41-45
Stevens- Johnson syndrome (SJS) is a severe and life-threatening condition. Although allopurinol, an antihyperuricemia drug, is the drug most commonly associated with SJS, more than 100 different causative drugs have been reported. Among hematologic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e99fdafb2f8a916ee8618e0142a9d0b
https://doi.org/10.1002/hon.1000
https://doi.org/10.1002/hon.1000
Autor:
Caterina Musolino, Emanuela Sant’Antonio, Alessandro Allegra, Antonino Cannavò, Giuseppa Penna, Demetrio Gerace, Arianna D'Angelo, Sabina Russo, Andrea Alonci
Publikováno v:
European Journal of Haematology. 86:93-110
Despite advances in understanding the molecular pathogenesis of multiple myeloma and promising new therapies, almost all patients eventually relapse with resistant disease. There is therefore a strong rationale for combining novel therapies that targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a4e591fa07da70c55da70f42c536f9e
https://doi.org/10.1111/j.1600-0609.2010.01558.x
https://doi.org/10.1111/j.1600-0609.2010.01558.x
Autor:
Alessandro Allegra, Giuseppa Penna, Sabina Russo, Andrea Alonci, Antonino Cannavò, Salvatore Campo, Demetrio Gerace, Caterina Musolino, Giacomo Bellomo, Raffaella Centorrino, Annamaria Petrungaro
Publikováno v:
Leukemia & Lymphoma. 52:101-107
Neutrophil gelatinaase-associated lipocalin (NGAL) is a glycoprotein bound with matrix metalloproteinase-9 (MMP-9) in human neutrophils, and elevated tissue NGAL expression has been documented in different infectious and inflammatory conditions. Rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4be919c580545f22be20dbdc671229be
https://doi.org/10.3109/10428194.2010.531413
https://doi.org/10.3109/10428194.2010.531413